Article Details
Retrieved on: 2025-10-03 15:51:43
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... Roche's Lucentis (ranibizumab), and Fresenius Kabi's Tyenne, a biosimilar of Roche's Actemra (tocilizumab). These approvals are set to ...
Article found on: gabionline.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here